Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of OPC-41061 in patients with cardiac edema (congestive heart failure)
jRCT2080220038Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tolvaptan in heart failure (HF) and edema secondary to heart failure, sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)edema secondary to heart failure
Beyond the preview
Go deeper on jRCT2080220038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220038.